0001415889-23-004865.txt : 20230314 0001415889-23-004865.hdr.sgml : 20230314 20230314184602 ACCESSION NUMBER: 0001415889-23-004865 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230313 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gelder Mark S. MD CENTRAL INDEX KEY: 0001564390 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36020 FILM NUMBER: 23732605 MAIL ADDRESS: STREET 1: C/O A.P. PHARMA, INC. STREET 2: 123 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Onconova Therapeutics, Inc. CENTRAL INDEX KEY: 0001130598 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 BUSINESS PHONE: 267-759-3681 MAIL ADDRESS: STREET 1: 375 PHEASANT RUN CITY: NEWTOWN STATE: PA ZIP: 18940 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC. DATE OF NAME CHANGE: 20090526 FORMER COMPANY: FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC DATE OF NAME CHANGE: 20001226 4 1 form4-03142023_100352.xml X0306 4 2023-03-13 0001130598 Onconova Therapeutics, Inc. ONTX 0001564390 Gelder Mark S. MD C/O ONCONOVA THERAPEUTICS, INC 12 PENNS TRAIL NEWTOWN PA 18940 false true false false CHIEF MEDICAL OFFICER Stock Option (right to purchase) 0.73 2023-03-13 4 A 0 62000 0 A 2033-03-13 Common Stock 62000 62000 D Restricted Stock Units 2023-03-13 4 A 0 20667 0 A Common Stock 20667 20667 D These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years. Each restricted stock unit is convertible into one share of common stock. These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary /s/ Mark Guerin, Attorney-in-Fact 2023-03-14